ArticleFrontiers in pharmacology2022

The optimal first-line treatment for patients with left-sided RAS wild-type metastatic colorectal cancer: Double-drug regimen or triple-drug regimen therapy.

Changjing Cai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.